Literature DB >> 16802127

Bringing palliative care to a Canadian cancer center: the palliative care program at Princess Margaret Hospital.

Camilla Zimmermann1, Dori Seccareccia, Allyson Clarke, David Warr, Gary Rodin.   

Abstract

It is increasingly recognized that complete care of the patient with cancer includes palliative care, which is applicable early in the course of illness, in conjunction with life-prolonging treatment. Princess Margaret Hospital (PMH) is Canada's largest center for cancer care and research, and it is an international referral center for patients with cancer. The Palliative Care Program at PMH has developed into a comprehensive clinical, educational, and research program, with an acute palliative care unit, daily palliative care clinics, a cancer pain clinic, and a consultation service that sees urgent consultations on a same-day basis in inpatient and outpatient areas. We will describe the components, successes, and challenges of our program, which may be useful for others, who are developing palliative care programs in an academic setting.

Entities:  

Mesh:

Year:  2006        PMID: 16802127     DOI: 10.1007/s00520-006-0093-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  21 in total

1.  Dying in Canada: is it an institutionalized, technologically supported experience?

Authors:  D K Heyland; J V Lavery; J E Tranmer; S E Shortt; S J Taylor
Journal:  J Palliat Care       Date:  2000-10       Impact factor: 2.250

2.  The development of palliative care at the University of Texas M.D. Anderson Cancer Center.

Authors:  E Bruera; C Sweeney
Journal:  Support Care Cancer       Date:  2001-07       Impact factor: 3.603

3.  The denial of death thesis: sociological critique and implications for palliative care.

Authors:  Camilla Zimmermann; Gary Rodin
Journal:  Palliat Med       Date:  2004-03       Impact factor: 4.762

Review 4.  Cancer pain.

Authors:  Eduardo Bruera; Hak Nam Kim
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272

Review 5.  Palliative care in Edmonton.

Authors:  R L Fainsinger
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

6.  Multidisciplinary symptom control clinic in a cancer center: a retrospective study.

Authors:  E Bruera; M Michaud; A Vigano; C M Neumann; S Watanabe; J Hanson
Journal:  Support Care Cancer       Date:  2001-05       Impact factor: 3.603

7.  Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.

Authors:  P Haddad; R K S Wong; G R Pond; F Soban; D Williams; M McLean; W Levin; A Bezjak
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

8.  Frequency of symptom distress and poor prognostic indicators in palliative cancer patients admitted to a tertiary palliative care unit, hospices, and acute care hospitals.

Authors:  E Bruera; C Neumann; C Brenneis; H Quan
Journal:  J Palliat Care       Date:  2000       Impact factor: 2.250

9.  Secondary and tertiary palliative care in US hospitals.

Authors:  Charles F von Gunten
Journal:  JAMA       Date:  2002-02-20       Impact factor: 56.272

10.  Common symptoms in patients with advanced cancer.

Authors:  E B Curtis; R Krech; T D Walsh
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

View more
  16 in total

1.  Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer.

Authors:  Winson Y Cheung; Lisa W Le; Lucia Gagliese; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2010-03-24       Impact factor: 3.603

2.  Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.

Authors:  David Hui; Ahmed Elsayem; Shana Palla; Maxine De La Cruz; Zhijun Li; Sriram Yennurajalingam; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

3.  Palliative care in the outpatient oncology setting: evaluation of a practical set of referral criteria.

Authors:  Paul A Glare; Deborah Semple; Stacy M Stabler; Leonard B Saltz
Journal:  J Oncol Pract       Date:  2011-11       Impact factor: 3.840

4.  Integration of palliative medicine into routine oncological care: what does the evidence show us?

Authors:  David J Debono
Journal:  J Oncol Pract       Date:  2011-10-18       Impact factor: 3.840

Review 5.  Improving patient and caregiver outcomes in oncology: Team-based, timely, and targeted palliative care.

Authors:  David Hui; Breffni L Hannon; Camilla Zimmermann; Eduardo Bruera
Journal:  CA Cancer J Clin       Date:  2018-09-13       Impact factor: 508.702

6.  Symptom clusters in patients with advanced cancers.

Authors:  Winson Y Cheung; Lisa W Le; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2009-01-30       Impact factor: 3.603

7.  Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients.

Authors:  Camilla Zimmermann; Debika Burman; Shazeen Bandukwala; Dori Seccareccia; Ebru Kaya; John Bryson; Gary Rodin; Christopher Lo
Journal:  Support Care Cancer       Date:  2009-07-23       Impact factor: 3.603

8.  Futile medication use in terminally ill cancer patients.

Authors:  Rachel P Riechelmann; Monika K Krzyzanowska; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2008-11-22       Impact factor: 3.603

9.  The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer.

Authors:  Breffni Hannon; Nadia Swami; Ashley Pope; Gary Rodin; Elizabeth Dougherty; Ernie Mak; Subrata Banerjee; John Bryson; Julia Ridley; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2014-10-04       Impact factor: 3.603

10.  Symptom and medication profiles among cancer patients attending a palliative care clinic.

Authors:  Rachel P Riechelmann; Monika K Krzyzanowska; Aoife O'Carroll; Camilla Zimmermann
Journal:  Support Care Cancer       Date:  2007-04-12       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.